-
December 1: The Week in Cancer NewsFDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.
by Kevin McLaughlin
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
November 17: The Week in Cancer NewsStudy finds association between vitamin D levels and risk for peripheral neuropathy, and new report highlights rising lung cancer survival.
by Thomas Celona
-
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
-
November 10: The Week in Cancer NewsSun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.
by Eric Fitzsimmons
-
Against All OddsAt age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren
-
November 3: The Week in Cancer NewsRecommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and children with Down syndrome and leukemia face worse outcomes.
by Marci A. Landsmann
-
Finding the ‘Silent Killer’Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.
by Eve Spiegel
-
October 27: The Week in Cancer NewsLiving alone may increase the risk of cancer death, and cervical cancer study results called ‘remarkable.’
by Kevin McLaughlin
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
